companies / hbox-therapies-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 2,700,0002.7M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | Aachen | |
| industry | unknown | |
| stage | null |
HBOX Therapies makes MiRA, an extracorporeal device that oxygenates blood and removes CO2 directly, bypassing the lungs while letting patients keep breathing and recover. It is built for ICU patients in acute respiratory failure who fail non-invasive support. Its hyperbaric gas management and low-damage blood pump aim to be a less invasive alternative to mechanical ventilation.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2023-07-01 | grant | 2,700,0002.7M | null | ○ |
Apache HTTP Server 2.4.67, UNIX, apache 2.4.67
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |